Comparatively to the HFD/STZ-induced T2DM mice, surfactin treatment in the present study significantly increased the colon levels of Occludin and Claudin-1, further reducing intestinal permeability. This evidence concerns the gene CLDN1 and type 2 diabetes mellitus.